Meda Ab operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Meda Ab with three other
pharmaceutical manufacturers in Europe:
H. Lundbeck A/S
sales of 14.59 billion Danish Kroner [US$2.14 billion]
of which 22%
was Other Pharmaceuticals),
Stada Arzneimittel AG
(2.12 billion Euro [US$2.30 billion]
of which 58%
was Generics), and
based in France
(1.52 billion Euro [US$1.65 billion]
of which 73%
was Specialty Care).
Meda Ab reported sales of SEK 19.65 billion (US$2.20 billion)
December of 2015.
increase of 28.0%
versus 2014, when the company's sales were SEK 15.35 billion.
Sales at Meda Ab have increased during each of the previous five years
(and since 2010, sales have increased a total of 70%).
Sales of Otc saw an increase
that was more than double the company's growth rate: sales were up
62.4% in 2015, from
SEK 4.35 billion to SEK 7.07 billion.
Not all segments of Meda Ab experienced an increase in sales in 2015:
sales of Other Sales fell 14.4% to SEK 421.00 million.
(However, this segment's sales were only a very small portion of the company's overall sales).